Markel Group (MKL) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Achieved strong results across insurance, ventures, and investment engines in the first half of 2024, with improved underwriting profitability and record sales and earnings in ventures despite challenging market conditions.
Operating revenues increased 5% to $8.17 billion for the first half of 2024, with all business engines contributing; Q2 revenues were $3.70 billion, down from $4.14 billion in Q2 2023.
Net income to common shareholders was $1.27 billion for the first half, up from $1.17 billion year-over-year, despite Q2 net income declining to $249.7 million from $677.5 million in Q2 2023.
Recent acquisitions include a 98% stake in Valor Environmental for $156.4 million and complementary businesses for VSC and Costa Farms, reflecting disciplined capital deployment.
The company discontinued its intellectual property collateral protection insurance (IP CPI) product in early 2024 due to adverse loss development.
Financial highlights
Total revenues for the first half of 2024 were $8.2 billion, up 5% year-over-year; operating income for the period was $1.75 billion.
Net investment income surged 34% to $441 million for the first half, driven by higher yields and increased fixed maturity holdings.
Net investment gains were $772 million for the first half, but Q2 saw net investment losses of $130 million due to equity market movements.
Combined ratio for underwriting operations was 94.4% for the first half, up from 93.4% year-over-year, with Q2 at 93.5%.
Share repurchases totaled $260 million in H1 2024, reducing outstanding shares and enhancing per-share value.
Outlook and guidance
Management targets premium growth only in product lines with adequate rates and expects continued modest rate increases in select lines.
Ventures growth expected to moderate due to softer labor markets, inventory build-up, and higher interest rates, but long-term opportunities remain attractive.
The company anticipates possible additional losses from discontinued IP CPI product over the next 12–18 months, but does not expect future quarterly losses to exceed recent quarters.
Yield on fixed maturity securities anticipated to rise slightly as lower-yielding bonds mature.
Emphasizes long-term performance measurement to mitigate short-term volatility from market movements.
Latest events from Markel Group
- Board recommends all management proposals and opposes both shareholder proposals at the 2026 meeting.MKL
Proxy Filing6 Mar 2026 - Operating income rose to $3.2B, with broad-based growth and improved insurance profitability.MKL
Q4 20255 Feb 2026 - Net income and operating income surged, with robust investment gains and ongoing share repurchases.MKL
Q3 202417 Jan 2026 - Operating income jumped 27% to $3.71B, with improved insurance and major share repurchases.MKL
Q4 20248 Jan 2026 - Key votes include director elections, auditor ratification, and ESG-related shareholder proposals.MKL
Proxy Filing1 Dec 2025 - Board recommends director slate, performance-based pay, and opposes GHG and voting proposals.MKL
Proxy Filing1 Dec 2025 - Q1 2025 saw lower profits from investment losses, but insurance and capital positions improved.MKL
Q1 202529 Nov 2025 - Leadership overhaul and strategic realignment target compounding and insurance growth.MKL
Status Update29 Nov 2025 - Strong operating income and restructuring offset insurance pressures and wildfire losses.MKL
Q2 20254 Nov 2025